Cadila Healthcare informs about press release

24 Sep 2021 Evaluate

Cadila Healthcare has informed that it enclosed a copy of press release dated September 24, 2021 titled ‘Zydus Cadila receives final approval from USFDA for Apremilast Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1006.10 25.45 (2.60%)
08-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.00
Dr. Reddys Lab 6050.00
Cipla 1383.40
Zydus Lifesciences 1006.10
Lupin 1616.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.